Chris Garabedian

After a bruising turn as Sarepta CEO, Chris Garabedian is back in biotech with a new role as godfather to a bunch of startups
Endpoints
Thu, 05/18/17 - 09:46 am
Sarepta Therapeutics
Chris Garabedian
Xontogeny
startups
Sarepta Therapeutics CEO Chris Garabedian resigns
Marketwatch
Wed, 04/1/15 - 10:35 am
Sarepta Therapeutics
Chris Garabedian
Sarepta's CEO can reverse the company's downward trend with a stellar presentation tomorrow
Bizjournals.com
Thu, 01/15/15 - 08:55 am
Sarepta Therapeutics
Pharma CEOs
Chris Garabedian
JPMHC 2015
CEO Reasserts Control Over Biotech Developer of Muscular Dystrophy Drug
Bloomberg/Businessweek
Fri, 08/1/14 - 09:12 am
Pharma CEOs
Duchenne Muscular Dystrophy
eteplirsen
Chris Garabedian
Sarepta CEO: $125 Million Offering Demand Was Strong
TheStreet.com
Thu, 12/13/12 - 04:30 pm
Sarepta
Chris Garabedian